GMCM
APYX icon

Gruber & McBaine Capital Management’s Apyx Medical APYX Stock Holding History

Gruber & McBaine Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$1.47M Buy
525,000
+25,000
+5% +$68.8K 0.4% 84
2015
Q1 		$1.2M Buy
+500,000
New +$1.66M 0.32% 93

Other funds holding APYX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Gruber & McBaine Capital Management's APYX Position: Q2 2015 in Review

Gruber & McBaine Capital Management increased its Apyx Medical (APYX) stake by 5% in Q2 2015, buying an estimated $68.8K and bringing the position to 525,000 shares worth $1.47M. The position accounts for 0.4% of the portfolio, ranked #84.

Gruber & McBaine Capital Management first reported a position in APYX in Q1 2015 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold APYX as of Q2 2015.

  • Gruber & McBaine Capital Management held 525,000 shares of Apyx Medical worth $1.47M as of Q2 2015.
  • Gruber & McBaine Capital Management bought 25,000 Apyx Medical shares in Q2 2015, an estimated $68.8K.
  • Apyx Medical made up 0.4% of Gruber & McBaine Capital Management's portfolio in Q2 2015, its #84 holding.
  • Gruber & McBaine Capital Management first reported a position in Apyx Medical in Q1 2015 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2015.

Based on Gruber & McBaine Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.